The difference between the patient who gets cured after surgery, chemotherapy and event targeted therapies and who relapses with a small quantum of intrepid cancer cells is whether the Dendritic cell T cell complex could find and eliminate residual minimal tumour load. A very significant chapter in these battles has opened up with the Chimeric Antigen Receptor (CAR) Therapy. Many B cell Neoplasms express CD19. CARs can be engineered into viruses and expressed by T cells. CAR T cells with anti CD19 faculties can be transferred to the patient. This novel therapy shows many promises and raises new questions.
Keywords: mmunotherapy, Chimeric, T cell, Viruses, Dendritic cell
Warning: fopen(./published-articles/2/1/20170057/Putting viruses to work in CAR therapies.htm): failed to open stream: No such file or directory in /var/www/vhosts/ijmio.com/httpdocs/article.php on line 187
Unable to open file!